Phibro Animal Health Corporation
Every calculator, already run for PAHC
Open the full toolkit →You have the numbers on PAHC. Get the argument.
A written report on which of these readings actually decide the outcome for Phibro Animal Health Corporation, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
5 analysts covering PAHCAnalyst Price Target Disagreement for Phibro Animal Health Corporation
Wall Street's bull case implies +59% from the current price; the bear case implies +1%. A 58% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for PAHC
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Phibro Animal Health Corporation
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufac…
PAHC — frequently asked
Is PAHC a buy right now?
Wall Street's consensus rating on Phibro Animal Health Corporation is none across 5 analysts, with a mean price target of $44.00 (+27% vs. the current $34.56). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is PAHC overvalued?
PAHC trades at 14.2x trailing earnings. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is PAHC's next earnings date?
Phibro Animal Health Corporation is next scheduled to report earnings around Nov 4, 2026. A full PAHC research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Phibro Animal Health Corporation?
Analysts covering Phibro Animal Health Corporation (PAHC) range from a bear-case target of $35.00 to a bull-case high of $55.00, with a mean consensus target of $44.00 across 5 analysts. The spread of $20.00 (58% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Phibro Animal Health Corporation against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Phibro Animal Health Corporation
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full PAHC research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Phibro Animal Health Corporation, in minutes. 3 free reports included with every account — no credit card required.